Home Blunting the knife: development of vaccines targeting digestive proteases of blood-feeding helminth parasites
Article
Licensed
Unlicensed Requires Authentication

Blunting the knife: development of vaccines targeting digestive proteases of blood-feeding helminth parasites

  • Mark S. Pearson , Najju Ranjit and Alex Loukas
Published/Copyright: May 19, 2010
Biological Chemistry
From the journal Volume 391 Issue 8

Abstract

Proteases are pivotal to parasitism, mediating biological processes crucial to worm survival including larval migration through tissue, immune evasion/modulation and nutrient acquisition by the adult parasite. In haematophagous parasites, many of these proteolytic enzymes are secreted from the intestine (nematodes) or gastrodermis (trematodes) where they act to degrade host haemoglobin and serum proteins as part of the feeding process. These proteases are exposed to components of the immune system of the host when the worms ingest blood, and therefore present targets for the development of anti-helminth vaccines. The protective effects of current vaccine antigens against nematodes that infect humans (hookworm) and livestock (barber's pole worm) are based on haemoglobin-degrading intestinal proteases and act largely as a result of the neutralisation of these proteases by antibodies that are ingested with the blood-meal. In this review, we survey the current status of helminth proteases that show promise as vaccines and describe their vital contribution to a parasitic existence.


Corresponding author

Received: 2010-2-11
Accepted: 2010-3-15
Published Online: 2010-05-19
Published in Print: 2010-08-01

©2010 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Guest Editorial
  2. Highlight: The Biology of Proteolytic Systems
  3. Highlight: 6th General Meeting of the International Proteolysis Society
  4. Structure, mechanism and inhibition of γ-secretase and presenilin-like proteases
  5. Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions
  6. Pharmacogenetic features of cathepsin B inhibitors that improve memory deficit and reduce β-amyloid related to Alzheimer's disease
  7. Proteases in lymphocyte killer function: redundancy, polymorphism and questions remaining
  8. Pseudo-active sites of protease domains: HGF/Met and Sonic hedgehog signaling in cancer
  9. Proteolysis of platelet receptors in humans and other species
  10. Blunting the knife: development of vaccines targeting digestive proteases of blood-feeding helminth parasites
  11. Impaired turnover of autophagolysosomes in cathepsin L deficiency
  12. Nuclear cysteine cathepsin variants in thyroid carcinoma cells
  13. Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer
  14. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis
  15. Hydrophilic residues surrounding the S1 and S2 pockets contribute to dimerisation and catalysis in human dipeptidyl peptidase 8 (DP8)
  16. Molecular contortionism – on the physical limits of serpin ‘loop-sheet’ polymers
  17. The substrate specificity profile of human granzyme A
  18. Use of granzyme B-based fluorescent protein reporters to monitor granzyme distribution and granule integrity in live cells
Downloaded on 6.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/bc.2010.074/html
Scroll to top button